Company / Operating Income per Share
Vanda Pharmaceuticals Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.24
FY2025
5-year range
-$0.24 / $0.74
FY2021-FY2025
Trend
-317.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -318% YoY in FY2025, a notable deviation from the 9-year average annual change of -36%.
Based on SEC 10-K filings.
-0.24 in FY2025.
Declined from $0.74 to $-0.24 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 317.5% year-over-year.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.24 | -317.5% |
| FY2024 | $0.11 | -85.2% |
| FY2023 | $0.74 | +52.4% |
| FY2022 | $0.49 | +17.2% |
| FY2021 | $0.42 | +2.4% |
| FY2020 | $0.41 | +226.0% |
| FY2019 | -$0.32 | +22.1% |
| FY2018 | -$0.41 | +54.8% |
| FY2017 | -$0.91 | -294.9% |
| FY2016 | $0.47 | +191.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026